Nowicki MJ, Vigen C, Mack WJ, Seaberg E, Landay AL, Greenblatt R, Anastos K, Cohen M, Minkoff H, Levine AM: Association of cells with natural killer and NKT immunophenotype with incident cancers in HIV infected women. AIDS Res and Human Retroviruses 2008; 24:163-8.
Khalsa A, Karim R, Mack WJ, Minkoff H, Cohen M, Young M, Anastos K, Tien PC, Seaberg E, Levine AM: Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women’s Interagency HIV Study (WIHS). AIDS 2007; 21:2539-41.
Nowicki MJ, Karim R, Mack W, Levine AM: Correlates of CD4/CD8 Count in HIV-Negative Women of WIHS Cohort. Human Immunology. In press. 2007.
Lim ST, Fayad L, Tulpule A, Modiano M, Espina BM, Cabanillas F, Laffranchi B, Allievi C, Bernareggi A, Levine AM: A Phase I/II Trial of Pixantrone (BBR2778), Methylprednisolone, Cisplatin, and Cytosine Arabinoside (PSHAP) in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL). Leukemia and Lymphoma 2007; 48:374-80.
Levine AM: Hodgkin lymphoma: To the HAART of the Matter (Editorial). Blood 2006; 108:3630-31.
Levine AM: Monoclonal gammopathy associated with HIV infection: Commentary. Clin Infect Disease 2006; 43:1206-8.
Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA: Progressive prothrombotic state in women with advancing HIV disease. JAIDS 2006; 42:572-7.
Shaye OS and Levine AM: Marginal Zone Lymphoma. Jour NCCN 2006; 4:311-318.
Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Espina BM, Groshen SG, Masood R, Gill PS: Phase I study of anti-sense oligonucleotide against vascular endothelial growth factor (VEGF-AS): Decrease in plasma VEGF with potential clinical efficacy. J Clin Oncol 2006; 24: 1712-1719.
Levine AM, Karim R, Mack W, Gravink DJ, Anastos K, Young M, Cohen M, Newman M, Augenbraun M, Gange S, Watts DH: Neutropenia in HIV infection: Data from the Women’s Interagency HIV Study. Archives Internal Medicine, 2006; 166:405-410.
Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM: Prognostic factors in HIV related diffuse large cell lymphoma: Before versus after highly active antiretroviral therapy. J Clin Oncol 2005; 23: 8477-8482.
Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM: AIDS-Related Burkitt’s Lymphoma (HIV-BL) versus Diffuse Large cell Lymphoma (HIV-DLCL) in the Pre-HAART and HAART Eras: Significant Differences in Survival with Standard Chemotherapy. JCO 23:4430-4438, 2005.
Richardson JL, Mowicki M, Danley K, Martin EM, Cohen MH, Gonzalez R, Vassileva J, Levine AM: Neuropsychological functioning in a cohort of HIV and HCV infected women. AIDS 2005; 19(15):1659-1667.
Lim ST, Levine AM: Angiogenesis and Hematological Malignancies. Hematology 10:11-24, 2005.
Lim ST, Rubin N, Said J, Levine AM: Primary Effusion Lymphoma (PEL): Successful treatment with highly active antiretroviral therapy (HAART) and Rituximab. Ann Hematol 84:551-552, 2005.
Lim ST, Tupule A, Espina BM, Levine AM: Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 103:417-21, 2005.
Saag MS, Bowers P, Leitz GJ, Levine AM: Once weekly epoeitin alfa improves quality of life and increases hemoglobin in anemic HIV infected patients. AIDS Res Hum Retroviruses 20:1037-1045, 2004.
Levine AM, Tulpule A, Espina B, Sherrod A, Boswell WD, Lieberman RD, Nathwani BN, Welles L: Liposome encapsulated doxorubicin (Myocet) in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS related non-Hodgkin’s lymphoma: Results of therapy and correlates of response. J Clin Oncol 22:2662-2670, 2004.
Arzoo KK, Bu X, Espina BM, Seneviratne L, Nathwani B, Levine AM: T cell lymphoma in HIV infected patients. JAIDS 36:1020-1027, 2004.
Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM: Impact of highly active anti-retroviral therapy on anemia, and relationship between anemia and survival in a large cohort of HIV infected women: Women’s Interagency HIV Study. JAIDS 37:1245-1252, 2004.
Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia D, Levine AM: Cancer risk among participants in the Women’s Interagency HIV Study (WIHS). JAIDS 36:978-985, 2004.
Machida K, Cheng KTN, Sung VMH, Shimodaira S, Lindsay KL, Levine AM, Lai M-Y, Lai MMC: Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protoooncogenes. Proc Nat Acad Sci, USA 101:4262-4267, 2004.
Tulpule A, Espina BM, Santabarbara ABP, Palmer M, Schiflett J, Boswell W, Smith S, Levine AM: Treatment of AIDS related non-Hodgkin’s lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: Results of a Phase II study. Investigational New Drugs 22:63-68, 2004.
Levine AM, Shimodaira S, Lai MMC: Treatment of HCV related mantle cell lymphoma with ribavirin and pegylated interferon alfa. N Engl J Med 349:2078-79, 2003.
Stripecke R, Koya RC, Ta HQ, Kasahara N, Levine AM: The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells, Molecules and Diseases 31:28-37, 2003.
Levine AM: Challenges in the management of Burkitt's lymphoma. Clinical Lymphoma 3:S19-25, 2002.
Levine AM: Evaluation and management of the HIV infected woman: Review. Annals Intern Med 136:228-242, 2002.
Preston-Martin S, Kirstein L, Pagoda JM, Melnick SL, Masri-Lavine L, Silver S, Hessol N, French AL, Feldman J, Sacks HS, Rimer B, Deely M, Levine AM: Use of mammographic screening by HIV infected women in the Women’s Interagency HIV Study. Preventive Medicine 34:386-392, 2002.
Levine AM, Sadeghi S, Espina B, Tulpule A, Nathwani B: Characteristics of indolent non-Hodgkin’s lymphoma in patients with type 1 Human Immunodeficiency Virus infection. Cancer 94:1500-1506, 2002.
Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM: Multidrug resistance (MDR-1) expression in AIDS related lymphomas. Leukemia Research 26:121-127, 2002.
Seneviratne L, Tulpule A, Espina BM, Chen JA, Nathwani B, Levine AM: Clinical, immunologic and pathologic correlates of bone marrow involvement in 291 patients with AIDS-related lymphoma. Blood 98:2358-2363, 2001.
Bi J, Espina BM, Tulpule A, Boswell W, Levine AM: High dose cytosine arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS related non-Hodgkin’s lymphoma. J AIDS 28:416-421, 2001.
Nelson RA, Levine AM, Bernstein L: Reproductive factors and risk of intermediate or high grade B cell non-Hodgkin’s lymphoma in women. J Clin Oncol 19:1381-1387, 2001.
Levine AM, Berhane K, Masri-Lavine L, Sanchez ML, Young M, Augenbraun M, Cohen MN, Anastos K, Newman M, Gange SJ, Watts H: Prevalence and correlates of anemia in a large cohort of HIV infected women: Women’s Interagency HIV Study. JAIDS 26:28-35, 2001.
Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS: Evolving characteristics of AIDS related lympomas. Blood 96:4084-4090, 2000.
Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, Ratner L: ABVD chemotherapy with G-CSF in HIV infected patients with newly diagnosed Hodgkin’s Disease: A prospective, multi-institutional AIDS Clinical Trials Group Study (ACTG # 149). J AIDS 24:444-450, 2000.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.